Eli Mohamad, MSc
Eli Mohamad, MSc, is President of the Space Biostasis Coalition and Cofounder of the decentralized research organizations CryoDAO and HydraDAO. A six-time entrepreneur across AI, fintech, biotech, and decentralized science, he previously cofounded the biopreservation company X-Therma and the nonprofit Organ Preservation Alliance, and he has directly raised more than $250 million over his career.
Since December 2025, Eli has led the Space Biostasis Coalition (SBC), a Swiss-US nonprofit research association dedicated to accelerating human biostasis, the controlled suppression of metabolism, as a critical technology for long-duration space exploration. SBC unites researchers, engineers, and policymakers and aims to mobilize $1 billion in frontier biostasis research funding.
The coalition is convening the inaugural Space Biostasis Summit at Space Center Houston in February 2027, bringing together more than 300 researchers, engineers, entrepreneurs, astronauts, and policymakers under the theme Opportunities in Engineering Suspended Animation for Space Exploration. Read his Our mission: becoming multiplanetary and The Inaugural Space Biostasis Summit Is Coming to Houston.
Since June 2023, Eli has been a Core Team Member of CryoDAO, a decentralized autonomous organization that funds and implements frontier research in cryopreservation. Listed among its cofounders alongside our Kai Micah Mills and our Emil Kendziorra, he helps steer a community-governed treasury of more than $5 million that has funded six research projects, guided by scientific advisors including our Gregory M. Fahy, João Pedro de Magalhães, and Roman Bauer.
Its project portfolio ranges from multi-organ cryopreservation with ultrasound rewarming in a pig model to the in vitro fertilization and cryopreservation of embryos derived from the RR-20 space mice colony. He is also Cofounder and Funding Lead of HydraDAO, a sister organization with Mills and Kendziorra that funds and incubates research into partial and whole-body biological replacement, with the goal of radically extending the human lifespan.
Between 2016 and 2020, Eli helped build X-Therma, the biopreservation company led by founder and CEO Xiaoxi Wei that develops nontoxic, ice-free technology inspired by nature's antifreeze mechanisms for the long-term subzero storage of organs, tissues, and cells. He served as Strategic Advisor from 2016 to 2019 and then as Cofounder and Chief Business Officer from 2019 to 2020. Watch his Foresight Institute talk Eli Mohamad, X-Therma: Recent Breakthroughs for Ending the Organ Transplant Waitlist.
From 2013 to 2017, Eli was a Cofounder of the Organ Preservation Alliance, a nonprofit created to jump-start the research field of cell, tissue, and organ cryopreservation and to carry progress from lab to clinic. Working with the U.S. Department of Defense, the White House, and an alliance of stakeholders, the Alliance helped liberate more than $300 million in research funding. Its early milestones include the first Global Organ Banking Summit at Stanford School of Medicine in 2015, a White House roundtable on organ cryobanking and regenerative medicine, and Department of Defense grant pipelines for organ and tissue preservation.
Eli's financing experience spans biotech and advanced mobility. From 2017 to 2019, he was Chief Business Officer at Rimac Automobili, the Croatian manufacturer of high-performance electric vehicles, where he led the company's Series B and C funding rounds and raised over $150 million. He then advised Rimac on financing and strategy until 2020.
Between 2016 and 2017, he was CFO/CBO at Insilico Medicine, the AI drug discovery company founded by our Alex Zhavoronkov, where he led its Series A financing and worked on early strategy for Juvenescence. From 2022 to 2025, he was Entrepreneur in Residence at Narwhal Sciences and CEO of Fraktus, an operating system for the Web3 robot economy.
Earlier, between 2013 and 2014, Eli was Cofounder and CEO of Walkmore, a SaaS big data analytics company for financial institutions that he built and sold within 18 months. From 2014 to 2015, he was Cofounder and COO of Orphidia Ltd, a London and San Francisco medical diagnostics startup developing a handheld device that reads multiple biomarkers on a single chip from a drop of blood.
Before turning to startups, he spent a decade in management consulting at firms including Helsinki Consulting Group, Horatio Consulting, VAPS Business Consulting, and Sense Consulting, working on EU-funded projects, regulatory reform, and innovation management. At VAPS, he led a team of consultants commercializing a proprietary technology for the British defense contractor QinetiQ, and as an analyst at Hitrorez he worked on a regulatory guillotine project reviewing Croatian regulations at the national level.
Eli earned his BSc in Service Management in 2004 from the Rochester Institute of Technology and his MSc in Technology and Innovation Management in 2008 from the University of Sussex. In 2012, he was one of 80 participants selected from more than 3,000 applicants for Singularity University's Graduate Studies Program at NASA Research Park. In 2007, he received a Ryoichi Sasakawa Fellowship from the Tokyo Foundation and a Leadership Development Program Scholarship from the College of Europe, Transfuse, and the Robert Bosch Foundation.
Eli speaks frequently on biostasis and longevity. He was a featured speaker at the Global Cryonics Summit in Miami in 2024 and spoke in the Science of Biostasis track at Vitalist Bay in Berkeley in 2026.
Watch Eli Mohamad & Kai Micah Mills – Advancing Frontiers Of Cryopreservation & Biological Replacement, his 2025 conversation with our Mills on our Ira S. Pastor's Progress, Potential, and Possibilities.
Visit his LinkedIn profile, Foresight Institute profile, about.me page, and Medium profile. Follow him on Instagram and X.